Kindly sponsored by Precision for Medicine
This session will feature a 15 minute presentation from Sonali Mohapatra, Quantum Innovation Sector Lead at the National Quantum Computing Centre (NQCC) on the potential impact that Quantum Computing will have on drug discovery. Followed by an investment update from David Grimm, Investment Director at Albion VC. David manages the UCL Technology Fund’s Computer and Physical Sciences investment team. Investing in a wide range of exciting deeptech opportunities, including Quantum Computing, Machine Learning and Data Analytics, Cleantech, Medtech, Edtech and Hardware.
There will be the opportunity for audience Q&A after the presentations.
Kindly sponsored by FUJIFILM Diosynth Biotechnologies
Kindly sponsored by Ipsen
Kindly sponsored by Syneos Health
BioTrinity Panels, Interviews & Keynotes
We aim to deliver a well-rounded programme of presentations, discussions, and debate around a variety of subject matters prevalent in the life sciences industry today. We include a mix of scientific focused topics, which either address the latest innovation and research, or matters that are popular and much talked about in the current mainstream landscape, along with pertinent updates on the financing and investment landscapes, as well as regulatory and legislative updates from leading voices and decision makers.
We cover a lot of ground, and the range is broad, but we aim to support our delegates by delivering a programme that is digestible, useful, and thought-provoking.
Each R&D spotlight will include 5 x 10 minute company presentations from the most innovative companies working in; Oncology, Infectious Diseases, Microbiome, Rare Diseases, Medtech, Neuroscience, Inflammatory Disease and Cell and Gene Therapy. If you are a company seeking Series A investment or to partner assets, BioTrinity is for you! Contact events@obn.org.uk
Detailed below is an outline of all of the sessions, if you have any queries then please email events@obn.org.uk